Comparison of efficacy and safety of insulin detemir and insulin semilente MC [insulin zinc suspension amorphous] in children, adolescents and young adults with type 1 diabetes on basal-bolus regimen.
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Insulin detemir (Primary) ; Insulin zinc suspension amorphous
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 07 Jul 2009 Actual patient number (71) added as reported by ClinicalTrials.gov.
- 07 Jul 2009 Actual end date (Nov 2005) added as reported by ClinicalTrials.gov.
- 24 Mar 2009 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.